FFO

Fortitude Family Office Portfolio holdings

AUM $445M
1-Year Est. Return 21.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+21.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$427M
AUM Growth
+$57.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,172
New
Increased
Reduced
Closed

Top Buys

1 +$21.3M
2 +$7.93M
3 +$6.06M
4
CVX icon
Chevron
CVX
+$5.4M
5
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$3.62M

Sector Composition

1 Technology 8.14%
2 Industrials 4.37%
3 Financials 4.03%
4 Healthcare 2.49%
5 Communication Services 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNF icon
1651
Unifirst Corp
UNF
$4.71B
$579 ﹤0.01%
3
-2
FLO icon
1652
Flowers Foods
FLO
$1.86B
$577 ﹤0.01%
53
-924
ORN icon
1653
Orion Group Holdings
ORN
$493M
$577 ﹤0.01%
58
WAFD icon
1654
WaFd
WAFD
$2.6B
$577 ﹤0.01%
18
-12
WMK icon
1655
Weis Markets
WMK
$1.7B
$577 ﹤0.01%
9
-25
RCKT icon
1656
Rocket Pharmaceuticals
RCKT
$384M
$576 ﹤0.01%
+164
HCI icon
1657
HCI Group
HCI
$2.04B
$575 ﹤0.01%
3
KAI icon
1658
Kadant
KAI
$3.69B
$570 ﹤0.01%
2
-1
NTNX icon
1659
Nutanix
NTNX
$10.8B
$569 ﹤0.01%
11
-58
OTTR icon
1660
Otter Tail
OTTR
$3.7B
$566 ﹤0.01%
7
-5
BMEA icon
1661
Biomea Fusion
BMEA
$137M
$563 ﹤0.01%
454
+158
ACAD icon
1662
Acadia Pharmaceuticals
ACAD
$3.74B
$561 ﹤0.01%
21
-11
ALRM icon
1663
Alarm.com
ALRM
$2.22B
$561 ﹤0.01%
11
-2
UTMD icon
1664
Utah Medical Products
UTMD
$214M
$560 ﹤0.01%
10
-202
MRNA icon
1665
Moderna
MRNA
$20.1B
$560 ﹤0.01%
19
-46
EWCZ icon
1666
European Wax Center
EWCZ
$258M
$558 ﹤0.01%
155
-251
HMN icon
1667
Horace Mann Educators
HMN
$1.84B
$554 ﹤0.01%
12
VVV icon
1668
Valvoline
VVV
$4.23B
$552 ﹤0.01%
19
-17
PRM icon
1669
Perimeter Solutions
PRM
$5.03B
$551 ﹤0.01%
+20
GSAT icon
1670
Globalstar
GSAT
$10.5B
$549 ﹤0.01%
9
-1,011
XFOR icon
1671
X4 Pharmaceuticals
XFOR
$374M
$548 ﹤0.01%
+137
UAA icon
1672
Under Armour
UAA
$2.64B
$547 ﹤0.01%
110
+55
ALCO icon
1673
Alico
ALCO
$324M
$546 ﹤0.01%
15
OI icon
1674
O-I Glass
OI
$1.64B
$546 ﹤0.01%
37
-26
TVRD
1675
Tvardi Therapeutics
TVRD
$29.1M
$546 ﹤0.01%
+127